Front Page Demo Slide

HIPPA & HL7

1
2
3
4
LATEST NEWS:   Regeneron-Sanofi drug succeeds mid-stage study - (Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study.
LATEST NEWS:   Intensive resistance training safe, effective for women with osteoporosis - (Reuters Health) - High-intensity resistance and impact training (HiRIT) may improve bone and muscle strength in select postmenopausal women with osteoporosis, according to a small study in Australia.
LATEST NEWS:   U.S. judge in Texas invalidates Allergan patents on Restasis - (Reuters) - A U.S. judge on Monday invalidated patents on Allergan Plc's dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious, sending shares of the pharmaceutical company down 3.5 percent.
LATEST NEWS:   More men than women infected with oral human papillomavirus - (Reuters Health) - Roughly one in nine U.S. men have oral infections of the cancer-causing human papillomavirus (HPV), more than triple the infection rate for women, a new study suggests.
LATEST NEWS:   Trump says he will 'look into' drug czar pick following report - WASHINGTON (Reuters) - U.S. President Donald Trump said on Monday that he would "look into" a report that his nomination for drug czar championed a law weakening the Drug Enforcement Administration's capacity to slow the flow of drugs that have fueled the country's opioid epidemic.
LATEST NEWS:   Some mothers may not seek early help for kids with developmental delays - (Reuters Health) - When mothers trust their friends and neighbors more than doctors or struggle to access or afford care, they may be less likely to seek out medical help for young kids with developmental delays, a small U.S. study suggests.
LATEST NEWS:   Exelixis drug improves overall survival in liver cancer patients - (Reuters) - Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent.
LATEST NEWS:   Aimmune teams with Regeneron, Sanofi on peanut allergy drug - (Reuters) - Aimmune Therapeutics Inc said on Monday it would collaborate with Regeneron Pharmaceuticals Inc and Sanofi to develop its experimental peanut allergy drug.
LATEST NEWS:   BrainStorm enrolls first patients in advanced ALS stem cell trial - TEL AVIV (Reuters) - BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) at Massachusetts General Hospital and UC Irvine Medical Center in California.